Related content

Pharmakogenomik maligner Tumoren: Bedeutung von Zellzyklus- und Apoptosedefekten für Therapieansprechen und Krankheitsprognose

By Daniel P.   Sturm I.   Hemmati P.   Güner D.  

Der Onkologe, Vol. 10, Iss. 1, 2004-01 ,pp. : 46-54

Springer Publishing Company

Access to resources Recommend Favorite

Therapie mit ,,small molecules“: Grundlagen und klinische Problematik in der Anwendung bei soliden Tumoren

By Hohenberger P.  

Der Onkologe, Vol. 10, Iss. 1, 2004-01 ,pp. : 38-45

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of Level of NKG2D Ligands between Normal and Tumor Tissue Using Multiplex RT-PCR

By Park Soon-Won   Bae Jae-Ho   Kim Sang-Doo   Son Young-Ok   Kim Joo-Young   Park Hyun-Jin   Lee Chang-Hun   Park Do-Youn   Kim Jee-Yeon   Lee Min-Ki   Chung Byung-Seon   Kim Sun-Hee   Kang Chi-Dug  

Cancer Investigation, Vol. 25, Iss. 5, 2007-07 ,pp. : 299-307

Informa Healthcare

Access to resources Recommend Favorite

Possible association of decreased NKG2D expression levels and suppression of the activity of natural killer cells in patients with colorectal cancer

By                            

International Journal of Oncology, Vol. 40, Iss. 4, 2012-01 ,pp. : 1285-1290

Spandidos Publications

Access to resources Recommend Favorite

Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients

By Konjević Gordana   Mirjačić Martinović Katarina   Vuletić Ana   Jović Viktor   Jurisić Vladimir   Babović Nada   Spužić Ivan  

Clinical and Experimental Metastasis, Vol. 24, Iss. 1, 2007-03 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite